Intrinsic Value of S&P & Nasdaq Contact Us

Kamada Ltd. KMDA NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
78/100
4/7 Pass
SharesGrow Intrinsic Value
$19.68
+133.7%
Analyst Price Target
$12.00
+42.5%

Stock Statistics — KMDA

Kamada Ltd. (KMDA) has a market capitalization of $485.72M and trades at $8.42. The 52-week range is 5.54-9.35.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 22.2, Earnings Per Share (EPS) of $0.38, annual revenue of $195.34M.

The stock has a beta of 0.31, a last dividend of $0.2500, operates in the Healthcare sector.

Trading Data
Current Price$8.42
52-Week Range5.54-9.35
Volume36.79K
Avg Volume (30D)73.48K
Market Cap$485.72M
Beta (1Y)0.31
Last Dividend$0.2500
Company
IPO Date2013-05-31
Employees420
CEOAmir London
CountryIL
ExchangeNASDAQ Global Select
CurrencyUSD
ISINIL0010941198
CUSIPM6240T109
Income (Latest Year)
Revenue$195.34M
Gross Profit$78.28M
EBITDA$44.54M
Operating Income$28.4M
Net Income$21.86M
EPS$0.38
EPS Diluted$0.37
Shares Outstanding$57.65M
Balance Sheet (Latest Year)
Total Assets$378.79M
Current Assets$193.12M
Cash & ST Investments$75.48M
Total Liabilities$109.66M
Total Debt$11.56M
Net Debt$-63.92M
Total Equity$269.13M
Debt / Equity0.04
Valuation Ratios
P/E Ratio22.2
P/S Ratio2.49
P/B Ratio1.8
EV/EBITDA (approx)10.9
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message